Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.54 CHF | -1.55% |
|
-0.81% | +10.22% |
06-14 | EU regulator mandates label updates on CAR-T cancer therapies | RE |
06-14 | PeptiDream and Novartis Agreement Becomes Effective with 28.3 Billion Yen Upfront Payment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.22% | 218B | |
+52.24% | 791B | |
+40.45% | 630B | |
+16.89% | 328B | |
+9.16% | 298B | |
+17.25% | 246B | |
+0.41% | 225B | |
+4.49% | 160B | |
-6.04% | 156B | |
-2.33% | 116B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis Presents Favorable Study Results for Rare Kidney Disease Medication Fabhalta